TickerFacts.

IceCure Medical Ltd. (ICCM): Cost of Revenue

Annual figures by period end, from SEC filings.

$2.15M
Year ended 2025-12-31
+9.5%
3-year compound annual growth
+8.6%
5-year compound annual growth
2019-12-31: $1.10M2020-12-31: $1.42M2021-12-31: $1.94M2022-12-31: $1.64M2023-12-31: $1.93M2024-12-31: $1.84M2025-12-31: $2.15M$2.15M
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$2.15M+17.0%2026-03-17, From 2025-01-01
2024-12-31$1.84M-4.6%2026-03-17, From 2024-01-01
2023-12-31$1.93M+17.6%2026-03-17, From 2023-01-01
2022-12-31$1.64M-15.6%2025-03-27, From 2022-01-01
2021-12-31$1.94M+36.4%2024-04-03, From 2021-01-01
2020-12-31$1.42M+29.1%2023-03-29, From 2020-01-01
2019-12-31$1.10Mn/a2022-08-22, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
IceCure Medical Ltd. (ICCM)2025-12-31$2.15M+17.0%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%
Tenon Medical, Inc. (TNON)2025-12-31$1.59M+1.3%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.17M+19.9%
QHSLab, Inc. (USAQ)2025-12-31$880.9K+13.8%
Lucid Diagnostics Inc. (LUCD)2025-12-31$6.67M-6.0%
Picard Medical, Inc. (PMI)2025-12-31$5.14M+14.2%
Femasys Inc (FEMY)2025-12-31$872.4K+60.1%

Compare ICCM, AURX, OSRH, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗